A PSAN webinar with Diana Zuckerman with the National Center for Health Research

Date: Wednesday, Feb 21 Time: 2:00-3:00 pm Eastern Time Via Zoom (registration below) National health policy expert Diana Zuckerman, PhD, President of the National Center for Health Research, will discuss FDA standards for drugs and devices, including 510k clearances, which are lowering and putting patients at risk of harm. A Q&A will follow her presentation.

Diana Zuckerman is President of the National Center for Health Research (NCHR), a nonprofit public health think tank that conducts and analyzes research on a wide range of healthcare and health policy issues and uses the results to inform policies and programs affecting the health of adults and children. She has testified about the safety and effectiveness of medical and consumer products before Congress, federal agencies, state legislative committees, and the Canadian Parliament.

After serving on the faculty of Vassar and Yale and as a researcher at Harvard, Dr. Zuckerman went to Capitol Hill as a AAAS Congressional Science Fellow. Trained in epidemiology and public health at Yale Medical School, she worked for a dozen years as a Congressional staffer in the U.S. House of Representatives and Senate and was a senior policy advisor in the Clinton White House. While in her current position at NCHR, she was also a fellow at the University of Pennsylvania Center for Bioethics, and was the first non-physician elected to the Women in Medicine International Hall of Fame. She previously chaired Maryland’s Women’s Health Promotion Council and served on the CMS Medicare Evidence Development & Coverage Advisory Committee and the Board of Directors of the Reagan-Udall Foundation. She is currently on the Board of the nonprofit Alliance for a Stronger FDA. She is the author of five books and dozens of book chapters and articles in medical and academic journals and newspapers, has appeared in numerous documentaries on FDA-related issues, and is widely quoted in the media.